SecBot SecBot
DEFA14A ·Filed Apr 24, 2026

CGON

CG Oncology, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed6mo ago SEC0001193125-26-177424
Proxy solicitation materials
Actionable Insight • Neutral

This is a routine filing. Monitor the company's next earnings report for any updates on financial performance or strategic direction.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$66.82
T+0 close · Apr 24, 2026 · via day close
Latest settled
+3.73%
T+60 · $69.31
Vs SPY
−1.05%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 27 $66.82entry
  2. T+1 · 7mo ago −1.90%α −1.42% · $65.55
  3. T+5 · 7mo ago +1.32%α +0.92% · $67.70
  4. T+20 · 6mo ago −7.38%α −12.33% · $61.89
  5. T+60 · 4mo ago +3.73%α −1.05% · $69.31
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CG Oncology filed a definitive proxy statement (DEFA14A) for its upcoming shareholder meeting. This filing follows the recent appointment of Jim DeTore as CFO, which occurred near the same time as this proxy statement. The filing is routine and contains standard proxy information.

Key Financial Metrics

Vote
director election

Key Facts

  • CG Oncology filed a definitive proxy statement (DEFA14A) for its shareholder meeting.
  • The filing follows the recent appointment of Jim DeTore as CFO, which occurred 11 days prior.
  • The filing is a standard proxy statement with no indication of an activist campaign or contested vote.

Financial Impact

No immediate financial impact from this filing

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001193125-26-177424
Document: 0001193125-26-177424-index-headers.html0001193125-26-177424
Document: 0001193125-26-177424-index.html0001193125-26-177424
Document: 0001193125-26-177424.txt0001193125-26-177424

Track record

25 reports on CGON

Performance horizon

6 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +26.33% at T+20 after the Jun 12, 2026 report. 8 of 8 went positive at some point.

Filters
  1. Nov 16, 2026today 8-K Bullish 7/10 Entry $98.84 Now $84.78 −14.23% settles Dec 15
  2. Nov 16, 2026today Press Release Bullish 7/10 Entry $95.01 Now $84.78 −10.77% settles Dec 15
  3. Nov 6, 202610d ago 8-K Bearish 5/10 Entry $75.99 Now $84.78 −11.57% settles Dec 7
  4. Nov 6, 202610d ago Press Release Neutral 4/10 Entry $75.99 Now $84.78 +11.57% settles Dec 7
  5. Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $64.06 Now $84.78 +32.34% settles Dec 2
  6. Oct 19, 202628d ago 3 Neutral 2/10 Entry $61.93 Now $84.78 +36.90% settles Nov 17
  7. Oct 15, 20264w ago 144 Neutral 2/10 Entry $59.85 to $74.40 Now $84.78 +41.65% ▲ +24.31% +25.47% vs SPY
  8. Oct 12, 20265w ago Institutional Cluster Mixed 3/10 Entry $63.13 to $74.74 Now $84.78 +34.29% ▲ +18.39% +21.66% vs SPY
  9. Aug 6, 202614w ago Press Release Bearish 7/10 Entry $74.85 to $74.33 Now $84.78 −13.27% ▲ +0.69% +1.29% vs SPY
  10. Aug 6, 202614w ago 424B5 Bearish 6/10 Entry $74.85 to $74.33 Now $84.78 −13.27% ▲ +0.69% +1.29% vs SPY
Showing 10 of 25

US Market Status

Market Closed · Opens in 6h 21m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 24, 2026